The Prometheus League
Breaking News and Updates
- Abolition Of Work
- Ai
- Alt-right
- Alternative Medicine
- Antifa
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ascension
- Astronomy
- Atheism
- Atheist
- Atlas Shrugged
- Automation
- Ayn Rand
- Bahamas
- Bankruptcy
- Basic Income Guarantee
- Big Tech
- Bitcoin
- Black Lives Matter
- Blackjack
- Boca Chica Texas
- Brexit
- Caribbean
- Casino
- Casino Affiliate
- Cbd Oil
- Censorship
- Cf
- Chess Engines
- Childfree
- Cloning
- Cloud Computing
- Conscious Evolution
- Corona Virus
- Cosmic Heaven
- Covid-19
- Cryonics
- Cryptocurrency
- Cyberpunk
- Darwinism
- Democrat
- Designer Babies
- DNA
- Donald Trump
- Eczema
- Elon Musk
- Entheogens
- Ethical Egoism
- Eugenic Concepts
- Eugenics
- Euthanasia
- Evolution
- Extropian
- Extropianism
- Extropy
- Fake News
- Federalism
- Federalist
- Fifth Amendment
- Fifth Amendment
- Financial Independence
- First Amendment
- Fiscal Freedom
- Food Supplements
- Fourth Amendment
- Fourth Amendment
- Free Speech
- Freedom
- Freedom of Speech
- Futurism
- Futurist
- Gambling
- Gene Medicine
- Genetic Engineering
- Genome
- Germ Warfare
- Golden Rule
- Government Oppression
- Hedonism
- High Seas
- History
- Hubble Telescope
- Human Genetic Engineering
- Human Genetics
- Human Immortality
- Human Longevity
- Illuminati
- Immortality
- Immortality Medicine
- Intentional Communities
- Jacinda Ardern
- Jitsi
- Jordan Peterson
- Las Vegas
- Liberal
- Libertarian
- Libertarianism
- Liberty
- Life Extension
- Macau
- Marie Byrd Land
- Mars
- Mars Colonization
- Mars Colony
- Memetics
- Micronations
- Mind Uploading
- Minerva Reefs
- Modern Satanism
- Moon Colonization
- Nanotech
- National Vanguard
- NATO
- Neo-eugenics
- Neurohacking
- Neurotechnology
- New Utopia
- New Zealand
- Nihilism
- Nootropics
- NSA
- Oceania
- Offshore
- Olympics
- Online Casino
- Online Gambling
- Pantheism
- Personal Empowerment
- Poker
- Political Correctness
- Politically Incorrect
- Polygamy
- Populism
- Post Human
- Post Humanism
- Posthuman
- Posthumanism
- Private Islands
- Progress
- Proud Boys
- Psoriasis
- Psychedelics
- Putin
- Quantum Computing
- Quantum Physics
- Rationalism
- Republican
- Resource Based Economy
- Robotics
- Rockall
- Ron Paul
- Roulette
- Russia
- Sealand
- Seasteading
- Second Amendment
- Second Amendment
- Seychelles
- Singularitarianism
- Singularity
- Socio-economic Collapse
- Space Exploration
- Space Station
- Space Travel
- Spacex
- Sports Betting
- Sportsbook
- Superintelligence
- Survivalism
- Talmud
- Technology
- Teilhard De Charden
- Terraforming Mars
- The Singularity
- Tms
- Tor Browser
- Trance
- Transhuman
- Transhuman News
- Transhumanism
- Transhumanist
- Transtopian
- Transtopianism
- Ukraine
- Uncategorized
- Vaping
- Victimless Crimes
- Virtual Reality
- Wage Slavery
- War On Drugs
- Waveland
- Ww3
- Yahoo
- Zeitgeist Movement
-
Prometheism
-
Forbidden Fruit
-
The Evolutionary Perspective
Category Archives: Transhuman News
A diet for the cell: Keeping DNA fit with fewer calories
Posted: October 8, 2014 at 7:43 pm
Cells are generally able to repair spontaneous damage that arises in their genetic material. Unfortunately, the DNA repair process is not perfect and sometimes, damaged DNA gets passed on to newly made cells. A team of researchers at the Center for Molecular Biology of Heidelberg University (ZMBH) has recently discovered that in yeast cells, the amount of nutrients that cells are exposed to can affect DNA surveillance and repair mechanisms and therefore the quality of their DNA. According to the research group leader, Dr. Brian Luke, this could potentially lead to new strategies to improve cancer therapies. Their findings have been published in the journal Cell Reports.
Cells harbour genetic material in the form of DNA, which contains all the information required for the cell to function. Every time a cell divides this information has to be precisely copied so that the newly made cell receives a perfect replica in order that it, too, can function properly. The inheritance of damaged DNA, however, must be inhibited. In order to recognise altered DNA and prevent it from getting passed on to daughter cells, cells have developed surveillance mechanisms, or checkpoints. Checkpoints stop cells from dividing; thereby allowing more time for the cell to repair damaged genetic material. In some cases, however, the DNA cannot be efficiently repaired even though the checkpoints have been activated. If DNA damage persists for a very long time the cells may eventually turn the checkpoints off without waiting for the DNA to get repaired. This process, referred to as adaptation, may initially seem advantageous to the cell because it can finally grow again. "However, for the whole organism, adaptation is often dangerous, as the unrepaired DNA may lead to diseases such as cancer," points out Dr. Luke.
The molecular biologists Julia Klermund and Katharina Bender in the team of Brian Luke have found a way to prevent cells from turning off the checkpoint and therefore increase the time available for repair, while at the same time preventing damaged DNA from getting passed to newly made cells. The researchers discovered that the amount of nutrients in the cellular environment is a major factor influencing this process. When cells with DNA damage are exposed to low levels of nutrients, they do not adapt and instead remain fully arrested with an active checkpoint. The same effect was observed when cells with DNA damage were treated with the drug "rapamycin," which inhibits metabolic signalling and therefore mimics nutrient starvation. "The cells that are in low nutrient conditions end up being much more viable, likely because they have waited for the damaged DNA to be repaired before starting to divide again," explains Julia Klermund. "We believe that high nutrients are pushing cells to grow and proliferate even when the cells should not, e.g. with damaged DNA. Low nutrient conditions likely ensure that cells will only 'risk' dividing when the DNA has been completely repaired," adds Dr. Luke.
According to the Heidelberg scientist, research from the U.S.A. has recently demonstrated that nutrient starvation or rapamycin treatment can extend cell lifespan and also improve the efficacy of some types of chemotherapy. Brian Luke believes the study at the ZMBH may add important mechanistic details regarding how these effects are achieved and provides clues for further enhancement. Dr. Luke is a member of the DKFZ-ZMBH Alliance, a strategic collaboration between the German Cancer Research Center (DKFZ) and the Center for Molecular Biology of Heidelberg University. The research group of Dr. Luke is a member of the Network Aging Research (NAR). This work was initially funded by Heidelberg University's FRONTIER programme and eventually by the Collaborative Research Centre "Cellular Surveillance and Damage Response" (SFB 1036). Julia Klermund and Katharina Bender are PhD students in the team of Brian Luke.
Story Source:
The above story is based on materials provided by Heidelberg, Universitt. Note: Materials may be edited for content and length.
More:
A diet for the cell: Keeping DNA fit with fewer calories
Posted in DNA
Comments Off on A diet for the cell: Keeping DNA fit with fewer calories
Around the world in 400,000 years: Journey of the red fox
Posted: at 7:43 pm
Imagine attempting to trace your genetic history using only information from your mother's side. That's what scientists studying the evolution of the red fox had been doing for decades. Now, University of California, Davis, researchers have for the first time investigated ancestry across the red fox genome, including the Y chromosome, or paternal line. The data, compiled for over 1,000 individuals from all over the world, expose some surprises about the origins, journey and evolution of the red fox, the world's most widely distributed land carnivore.
"The genome and the information it contains about our ancestry and evolution is huge," said lead author Mark Statham, an assistant project scientist with the UC Davis Veterinary Genetics Laboratory. "If you're only looking at what your mother's mother's mother did, you're only getting a small portion of the story."
The study, published in the latest issue of the journal Molecular Ecology, represents the most globally comprehensive work yet on the red fox.
Conventional thinking based on maternal genetics suggested that red foxes of Eurasia and North America composed a single interconnected population across the Bering land bridge between Asia and Alaska. In contrast, this new research shows that the red foxes of North America and Eurasia have been almost entirely reproductively isolated from one another for roughly 400,000 years. During this time, the North American red fox evolved into a new species distinct from its Old World ancestors.
The previous view was distorted by the maternal picture because a single female line transferred from Asia to Alaska about 50,000 years ago.
The new genetic research further suggests that the first red foxes originated in the Middle East before beginning their journey of colonization across Eurasia to Siberia, across the Bering Strait and into North America, where they eventually founded the North American population.
"That small group that got across the Bering Strait went on to colonize a whole continent and are on their own evolutionary path," Statham said.
During the red foxes' journey over millennia, ice sheet formation and fluctuating temperatures and sea levels offered periods of isolation and reconnection, impacting their global distribution. Statham said understanding the evolutionary history of the red fox can provide insight into how other species may have responded to climate change and those same environmental shifts.
The research effort, headed by Statham and Ben Sacks, associate adjunct professor and director of the UC Davis Mammalian Ecology and Conservation Unit, involved a network of collaborators and contributors from around the world and relied heavily on specimens in natural history museums.
Story Source:
Read more:
Around the world in 400,000 years: Journey of the red fox
Posted in Genome
Comments Off on Around the world in 400,000 years: Journey of the red fox
Conspicuous tRNA lookalikes riddle the human genome
Posted: at 7:43 pm
PUBLIC RELEASE DATE:
8-Oct-2014
Contact: Edyta Zielinska edyta.zielinska@jefferson.edu 215-955-5291 Thomas Jefferson University @JeffersonUniv
(PHILADELPHIA) Transfer RNAs (tRNAs) are ancient workhorse molecules and part of the cellular process that creates the proteins, critical building blocks of life that keep a cell running smoothly. A new discovery suggests that the number of human genomic loci that might be coding for tRNAs is nearly double what is currently known. Most of the newly identified loci resemble the sequences of mitochondrial tRNAs suggesting unexpected new links between the human nuclear and mitochondrial genomes, links that are not currently understood.
Transfer RNAs (tRNAs) represent an integral component of the translation of a messenger RNA (mRNA) into an amino acid sequence. TRNAs are non-coding RNA molecules and can be found in all three kingdoms of life i.e., in archaea, bacteria and eukaryotes.
At the DNA level, a triplet of consecutive nucleotides known as the "codon" is used to encode an amino acid. Frequently, a given amino acid can be encoded by more than one codon: in fact, there are 61 distinct codons encoding the 20 standard human amino acids. During translation, each of the codons contained in the coding region of the mRNA at hand is recognized by its matching tRNA and the corresponding amino acid added to the nascent amino acid sequence. It has been known for many years that each of these 61 tRNAs has multiple copies spread throughout the genome that is found in the human nucleus. The presence of multiple genomic loci from which the same molecule can be made is a fairly standard trick of genomic organization: processing these loci in parallel can ensure that adequate amounts of each tRNA can be generated quickly enough to meet the high demand that the amino acid translation process imposes on the cell. In addition to the 61 tRNAs that are found in the human nuclear genome, 22 more tRNAs are encoded in the genome of the cellular organelle known as the mitochondrion: the mitochondrion, originally a bacterium itself, uses these 22 tRNAs to make proteins out of the just-over-a-dozen mRNAs that are encoded in its genome.
Recent research efforts have shown that tRNAs can have other roles, which go beyond their involvement in protein synthesis. For example, tRNAs can affect the physiology of a cell, they can modulate the abundance of important molecules, etc. These and other unexpected findings have revived interest in looking at tRNAs, this time under a different prism. But, how many tRNAs are actually encoded by the human genome and could be potentially involved in amino acid translation and other processes?
A team led by Isidore Rigoutsos, Director of the Computational Medicine Center at Thomas Jefferson University (TJU), set out to tackle this question and they have reported their findings in a study that was just published in the journal Frontiers in Genetics. "What we found, frankly, surprised us," said Rigoutsos.
The team searched the 3 billion base pairs of the human genome for DNA sequences that resembled the 530 known nuclear and mitochondrial tRNAs. Even though they used very stringent criteria in their searches, they found 454 "lookalike" loci, i.e., sequences that look like tRNA, but haven't yet been experimentally confirmed as such. The researchers found nearly as many as the known ones with which they started: 81% of these tRNA-lookalikes had not been reported previously. Rather unexpectedly, the team found that most of these new loci resembled some of the 22 mitochondrial tRNAs.
Interestingly, the discovered tRNA lookalikes are not spread uniformly across the 24 chromosomes. Instead, they have penetrated preferentially some chromosomes and have avoided others. For example, chromosomes 1, 2, 7, 8 and 9 claim the lion's share of the discovered tRNA-lookalikes. On the other hand, chromosome 18 contains no lookalikes. Also, some of the codons are particularly over-represented among the lookalikes whereas other codons are absent.
Posted in Genome
Comments Off on Conspicuous tRNA lookalikes riddle the human genome
UNCW, AARP partner to help with retirement issues
Posted: at 7:43 pm
Published: Tuesday, October 7, 2014 at 8:06 p.m. Last Modified: Tuesday, October 7, 2014 at 8:06 p.m.
Organizers of a new partnership between AARP and the University of North Carolina at Wilmington hope to make retirement better for the region's sizable 50-and-over population.
At a kick-off event Tuesday, leaders of the "Secure and Healthy Retirement Initiative" detailed plans for AARP-North Carolina and UNCW's College of Health and Human Services and Cameron School of Business to develop programs to help people plan, save for and enjoy retirement. The partnership is the first of its kind for AARP.
Charles Hardy, dean of health and human services at UNCW, said the area is "a destination for the 50-plus."
"We want to become a model for the nation of how public and private partnerships really advance the community's agenda," he said during the presentation.
While the initiative is in its beginning stages, AARP-NC Associate State Director Suzanne LaFollette-Black said some programs are getting started.
AARP has hired four interns from UNCW and hopes to recruit 100 local volunteers to teach public classes on finance, health and wellness and other issues related to retirement.
A symposium on care giving is in the works for mid-November as is one focused on business for early 2015.
The initiative will also include a research component, using university and AARP resources to gather data on issues facing retirees in Southeastern North Carolina.
"We want to empower people with resources and AARP has quite a few that are free as well as the university expertise," LaFollette-Black said.
Read more from the original source:
UNCW, AARP partner to help with retirement issues
Posted in Human Longevity
Comments Off on UNCW, AARP partner to help with retirement issues
The Honest Company Laundry Detergent Review – Eczema Prevention – Video
Posted: at 7:43 pm
The Honest Company Laundry Detergent Review - Eczema Prevention
This is my review of the honest laundry detergent and how it helped our kids to recover from eczema. More product info: https://www.honest.com/cleaning/hones...
By: anEdenLiving
More here:
The Honest Company Laundry Detergent Review - Eczema Prevention - Video
Posted in Eczema
Comments Off on The Honest Company Laundry Detergent Review – Eczema Prevention – Video
Can’t Get Rid of Your Ear Eczema Simple Solutions to Cure Ear Eczema – Video
Posted: at 7:43 pm
Can #39;t Get Rid of Your Ear Eczema Simple Solutions to Cure Ear Eczema
Can #39;t Get Rid of Your Ear Eczema Simple Solutions to Cure Ear Eczema Ear Eczema, otherwise known as otitis externa is an inflammation of the ear canal, which may be caused by infection, allergy...
By: wikieczem
Continued here:
Can't Get Rid of Your Ear Eczema Simple Solutions to Cure Ear Eczema - Video
Posted in Eczema
Comments Off on Can’t Get Rid of Your Ear Eczema Simple Solutions to Cure Ear Eczema – Video
Amgen'biosimilar Phase3 Plaque Psoriasis Study Met Primary Endpoint For Efficacy
Posted: at 7:42 pm
By RTT News, October 08, 2014, 09:23:00 AM EDT
(RTTNews.com) - Amgen ( AMGN ) announced its Phase 3 study evaluating efficacy and safety of biosimilar candidate ABP 501 compared with Humira (adalimumab) in patients with moderate-to-severe plaque psoriasis met its primary endpoint.
The primary endpoint was the Psoriasis Area and Severity Index (PASI) percent improvement from baseline to week 16 of treatment.
At week 16, the PASI percent improvement from baseline was within the prespecified equivalence margin for ABP 501 compared to adalimumab. Safety and immunogenicity of ABP 501 were comparable to adalimumab.
ABP 501 is being developed as a biosimilar to adalimumab, an anti-TNF- monoclonal antibody, which is approved in many countries for the treatment of inflammatory diseases, including rheumatoid arthritis, plaque psoriasis (PsO), polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease and ulcerative colitis.
"Results from Amgen's biosimilar Phase 3 plaque psoriasis study met the primary endpoint for efficacy and showed comparable safety and immunogenicity to adalimumab, which further demonstrates the Company's commitment to provide patients with access to high-quality medicines," said Sean Harper, M.D., executive vice president of Research and Development at Amgen.
Amgen said it has six biosimilar molecules in development and expects to launch the portfolio starting in 2017.
Psoriasis is a non-contagious chronic disease in which the immune system causes skin cells to grow at an accelerated rate. Instead of being shed, skin cells pile up, causing painful and itchy, red, scaly patches. Approximately 125 million people worldwide have psoriasis, and 80 percent of those patients have plaque psoriasis.
For comments and feedback: contact editorial@rttnews.com
See the rest here:
Amgen'biosimilar Phase3 Plaque Psoriasis Study Met Primary Endpoint For Efficacy
Posted in Psoriasis
Comments Off on Amgen'biosimilar Phase3 Plaque Psoriasis Study Met Primary Endpoint For Efficacy
Gene therapy shows promise for severe combined immunodeficiency
Posted: at 7:42 pm
PUBLIC RELEASE DATE:
8-Oct-2014
Contact: Hillary Hoffman hillary.hoffman@nih.gov 301-402-1663 NIH/National Institute of Allergy and Infectious Diseases @NIAIDNews
WHAT:
Researchers have found that gene therapy using a modified delivery system, or vector, can restore the immune systems of children with X-linked severe combined immunodeficiency (SCID-X1), a rare, life-threatening inherited condition that primarily affects boys. Previous efforts to treat SCID-X1 with gene therapy were initially successful, but approximately one-quarter of the children developed leukemia two to five years after treatment. Results from a study partially funded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), suggest that the new vector is equally effective at restoring immunity and may be safer than previous approaches.
In SCID-X1, mutations in a specific gene prevent the development of infection-fighting T cells. The standard therapy for SCID is transplantation of blood-forming stem cells, but some patients lack a suitable donor. In gene therapy, doctors remove stem cells from the patient's bone marrow, use a vector to insert a corrected gene and then return the corrected cells to the patient. Scientists suspect that the vectors used in earlier studies may have activated genes that control cell growth, contributing to leukemia.
In the current study, nine boys with SCID-X1 underwent gene therapy using a vector engineered by the study researchers. Seven boys developed functional T cells at levels comparable to those seen in previous studies and have remained healthy for one to three years after treatment. Analyses of the children's T cells suggest that the new vector causes fewer genomic changes that could be linked to leukemia. Researchers will continue to monitor the boys for leukemia development. Of the two other boys, one died of a pre-existing viral infection shortly after receiving the therapy, and one failed to develop corrected T cells and was given a stem cell transplant from an unrelated donor.
###
ARTICLE:
S Hacein-Bey-Abina, S-Y Pai et al. A modified y-retrovirus vector for X-linked severe combined immunodeficiency. New England Journal of Medicine DOI: 10.1056/NEJMoa1404588 (2014).
View post:
Gene therapy shows promise for severe combined immunodeficiency
Posted in Gene Medicine
Comments Off on Gene therapy shows promise for severe combined immunodeficiency
Lone Survivor Part 3 – Politically Incorrect – Video
Posted: at 7:42 pm
Lone Survivor Part 3 - Politically Incorrect
Part 3 of our Lone Survivor let #39;s play.
By: FireAndGloomGaming
View post:
Lone Survivor Part 3 - Politically Incorrect - Video
Posted in Politically Incorrect
Comments Off on Lone Survivor Part 3 – Politically Incorrect – Video
Hamlet 2 – Trailer – Video
Posted: at 7:42 pm
Hamlet 2 - Trailer
From the producers of Little Miss Sunshine comes a completely outrageous comedy about one of the most politically incorrect musical-theater extravaganzas ever seen!
By: UniversalMoviesINTL
Continued here:
Hamlet 2 - Trailer - Video
Posted in Politically Incorrect
Comments Off on Hamlet 2 – Trailer – Video